Trial Profile
Phase I/II study of multiclade HIV-1 DNA plasmid vaccine (VRC-HIVDNA016-00-CP)/adenovirus-5 vector (VRC-HIVADV014-00-VP) boost vaccine in HIV-1 uninfected adult Tanzanian volunteers
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs VRC-HIVADV014-00-VP (Primary) ; VRC-HIVDNA016-00-VP (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 05 Nov 2010 New trial record.